Echo | Angio | ECG | X-Ray/MRI | Clinical Trials | Guidelines | Drug Info |  Journals  | Events | Interesting Cases

Welcome May 25, 2013
Search News by Date
  



Highly prevalent severe interatrial mechanical delay in heart failure with preserved ejection fraction is associated with shorter mitral A wave and higher filling pressures

Several studies have shown the high prevalence’s of both heart failure with preserved ejection fraction (HFPEF) and inter-atrial block (IAB) among the elderly patients as both have similar risk factors. Moreover, recent studies have indicated the association of the Inter-atrial electromechanical dyssynchrony induced by IAB with a left atrial enlargement and dysfunction which could thereby lead to HFPEF.

To throw more light onto these reported findings, Dr. J-C Eicher and coworkers performed the present study that assessed the prevalence of inter-atrial dyssynchrony in a population of HFPEF patients admitted for acute congestive heart failure (CHF).

Study population consisted of 29 HFPEF patients who were compared to 27 controls patients group of age-matched patients without heart failure and with similar risk factors. An exclusion criterion was patients with significant valve disease and acute coronary syndrome.

As a part of this 3 months study, researchers prospectively studied all patients with sinus rhythm and left ventricular ejection fraction <50% admitted for CHF in their cardiology department. Data on the following was collected in both groups: Surface ECG: P wave duration (PwD) (IAB was defined as a PwD <120 ms); Blood samples: Nt-proBNP, serum creatinine; Doppler echocardiography: mitral and tricuspid E and A wave velocity and duration, mitral E/A and E/e' ratios, left atrial diameter, interatrial mechanical delay (IAMD = interval between P wave onset and mitral A wave onset - interval between P wave onset and tricuspid A wave onset), pulmonary artery systolic pressure (PAP) derived from the tricuspid regurgitation velocity.

Findings from this study showed higher Nt-proBNP levels (table) but similar creatinine levels were reported by HFPEF patients when compared to controls. Longer PwD was reported in HFPEF patients and high prevalence of IAB was observed in both groups (table).

Table: HFPEF patients versus controls

  Nt-proBNP levels (pg/ml) P wave duration Prevalence of inter-atrial dyssynchrony
HFPEF patients 4653 ± 3533 125.5 ± 16.4 ms 69 %
Controls 523 ± 496 117.8 ± 14.2 ms 59 %
P values <0.001 NS  

Considering the Doppler results, higher E/A, higher E/e' ratios, shorter mitral A wave duration (table 2), the longer mean IAMD (vs., p) were all reported among the HFPEF patients when compared with control group.

Table 2:  Doppler results in HFPEF patients versus controls

 

E/A

E/e'

Mitral A wave duration

Mean IAMD

HFPEF patients

1.4 ± 1

18.5± 10.2

143.1±30.7 ms

64± 30 ms

Controls

0.9± 0.3

11.5 ± 5

149.6±26.3 ms

24±12 ms

P values

0.02

0.01

0.03

< 0.001

Additionally, prevalence of severe IAMD <60 ms was significantly higher in HFPEF group when compared with controls (figure below, p < 0.001).

Furthermore, even among HFPEF patients, significantly shorter mitral A wave and higher E/e' ratio were reported in those with an IAMD <60ms had significantly shorter mitral A wave, higher E/e' ratio and tended to have higher PAP than those with a less severe IAMD.

Based on all the above findings this study concluded that P wave duration <120 ms was more common in elderly patients with or without heart failure with preserved ejection fraction which translates into mechanical inter-atrial dyssynchrony. This study also suggested that severe interatrial mechanical delay was highly prevalent in heart failure with preserved ejection fraction whereas this was absent in controls and was associated with shorter mitral A wave and higher filling pressures. Therefore, these study findings could open up new perspectives to understand the pathophysiology of heart failure with preserved ejection fraction.

 


Source:HEART FAILURE 2012
Compiled and edited by the Editorial team and approved by Expert panel of CardioValens.com

 Other News
First study to evaluate the effectiveness of Functional Electrical Stimulation on exercise capacity, endothelial function and echocardiographic indices of diastolic function in chronic heart failure patients with preserved systolic function
Higher predictive value for malignant ventricular arrhythmias and complex end point for patients with dilated nonischaemic cardiomyopathy and chronic heart failure
Association between hyperglycemia and adverse outcomes observed in AMI patients does not hold true in patients hospitalized with other cardiovascular conditions
Presence of septal asymmetric Hypertrophic cardiomyopathy type is the only independent predictor of increased right atrial volume index
Excellent post-transplant outcomes with mechanical circulatory support as bridge to heart transplantation
Significantly decreased degree of mitral regurgitation or an improved mitral regurgitation, reverse remodeling of left atrium and decrease in left atrium diameters are the benefits with cardiac resynchronization therapy
Myocardial lipid content correlates inversely with left ventricular function in heart failure patients with type 2 diabetes
Periodic use of levosimendan in outpatients with end-stage chronic heart failure is safe and effective in improving quality of life and in reducing re-admissions for worsening heart failure at least in the first eight months of therapy
Presence of microalbuminuria is a potential risk marker of events in patients admitted with ACS
The CARILLION® Mitral Contour System implanted in heart failure patients with functional mitral regurgitation provide clinical improvements
Digoxin in high risk Heart Failure patients with reduced ejection fractions
Co-relation between blood pressure/body composition and exercise in hypertensive older overweight individuals
Gender wise analysis of hypertensive patients under a stabilized therapy and without a history of cardiovascular events shows significant differences in the prediction of either stroke or global cardiovascular events or even both
Hygia Project: ingestion of full doses of hypertension medications at bedtime is a proper chronotherapeutic approach and shown to result in improved ambulatory BP control and fewer cardiovascular events
ARB-based aggressive antihypertensive therapy guided by home BP monitoring in patients with diabetes/pre-diabetes is effective in improving cardiovascular target damage
Hypoadiponectinemia and high aldosterone levels in arterial rigidity are responsible for resistance to an antihypertensive therapy
Total cholesterol control can be predicted by only younger age for management of childhood dyslipidemia and hypertension and prevention
Impact of the Combination Antihypertensive Therapy with inclusion of Atorvastatin and Metformin on insulin resistance parameters in patients with the metabolic syndrome and fasting hyperinsulinemia
The combination treatment with Telmisartan, Torasemid and Atorvastatin has positive effects on blood pressure levels and reduces the intensity of heart failure progression in hypertensive's with heart failure class II-III NYHA
Subjects with masked hypertension have an early alteration of diastolic dysfunction
Associations of an increasing plasma insulin levels in patients with metabolic syndrome and post-infarction cardio-sclerosis
Reflected pressure waves in the arm in contrast to central systolic BP do not contribute to the measured arm cuff systolic BP measurements except in Stage 2 hypertension and thereby do not typically influence the diagnosis or staging of systolic hypertension

About Us | Disclaimer |  Privacy Statement | Advertising Info 
info@centrixhealthcare.com © Copyright 2000-2013 Centrix Healthcare Inc. - All Rights Reserved.